logo
Plus   Neg
Share
Email

Sage Therapeutics Pulls Back Off Best Levels But Remains Sharply Higher

After gapping open sharply higher, shares of Sage Therapeutics (SAGE) have pulled back off their best levels but continue to see substantial strength in afternoon Trading on Thursday. Sage is currently up by 74.4 percent after reaching a record intraday high.

The initial jump by Sage came after the biopharmaceutical company said its Phase 2 study of SAGE-217 showed a statistically significant mean reduction in the Hamilton Rating Scale for Depression.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Malaysia has filed criminal charges against Goldman Sachs and two of the bank's former employees in connection with a corruption and money laundering probe tied to that country's sovereign wealth fund, 1 Malaysia Development Bhd, or 1MDB. Shares of Goldman Sachs are losing more than 2 percent in regular trading on the New York Stock Exchange. Alphabet Inc.'s Google said Monday that it will expand its presence in New York City by investing over $1 billion in capital requirements to establish a new campus known as Google Hudson Square. Google noted that its investment in New York is a huge part of its commitment to grow and invest in U.S. facilities, offices and jobs. Blockchain and artificial intelligence are the fastest-growing job categories, according to a report published by LinkedIn, the networking platform for professionals. Blockchain Developer is topping the list amid the ongoing hype around blockchain and cryptocurrency. As per the Emerging Jobs Report for 2018, the U.S has seen a surge in demand for people with blockchain development skills.
Follow RTT